When to consider Sacral Neuromodulation: A Simple Guide
“When to consider sacral neuromodulation? Know its indications, procedure, pros and cons, costs, and real-life reviews to make informed decisions.
Dr Kent Sasse
How does incontinence affect daily life?
Incontinence affecting daily life? Find expert answers on urinary problems, lifestyle changes, and treatments with Dr. Sasse’s insightful guide.
Is insurance skipping GLP-1 for weight loss?
Wondering why “Insurance not covering GLP-1” despite its benefits? Get answers, learn cost-effective alternatives, and strategies to appeal denials.
Is Sacral Neuromodulation or Pelvic Floor Therapy Right for You?
Sacral neuromodulation vs pelvic floor therapy: explore efficacy, safety, and decide which treatment option suits your urinary and fecal incontinence needs best.
Is Axonics Therapy’s Success Rate High?
Curious on “Success rate of Axonics Therapy”? Garner insights in our detailed guide on its efficacy, ideal candidates, and side effects.
Can GLP-1 medications trigger mood shifts?
GLP-1 mood changes: exploring how these medications impact mood and mental health. Evidence-backed, this blog offers comprehensive insights for patients and physicians.
Can lifestyle changes enhance life for incontinence patients?
“Improved quality of life in incontinence patients explored. Learn lifestyle changes, treatments, products, and support to manage symptoms effectively.”
GLP-1 Pancreatitis Risk: What Are the Symptoms?
GLP-1 pancreatitis risk explored, linking GLP-1 to pancreatitis, and offering preventative strategies. Understand risks, symptoms, and help for GLP-1-related issues.
Living with Sacral Neuromodulation Implant: How Does It Affect Daily Life?
Living with a sacral neuromodulation implant? Explore its usage in treating conditions like overactive bladder, how the surgery works, and the impact on daily life.
**Does GLP-1 drugs cause dehydration?**
Facing dehydration from GLP-1 drugs? Get expert advice on causes, symptoms, and prevention strategies from Nevada Surgical’s Dr. Kent Sasse.